CSK and lung adenocarcinoma: Given previous evidence of a phosphorylated tyrosine site shifting upon c-Src kinase activity, this result raises the possibility that E-cadherin is subjected to Tyr-797 phosphorylation following c-Src activation in lung adenocarcinoma cells through an alternative molecular pathway.